InvestorsHub Logo
Followers 535
Posts 34188
Boards Moderated 5
Alias Born 02/28/2013

Re: resx18 post# 453

Friday, 10/27/2023 12:00:05 PM

Friday, October 27, 2023 12:00:05 PM

Post# of 510
"We feel that Excellos is an ideal partner for TCBP, sharing our entrepreneurial spirit and belief in a collaborative effort to advance cell therapies globally," commented CEO Bryan Kobel. "We believe this step materially strengthens our ability to deliver on multiple clinical fronts and creates economic efficiencies within our production planning, while also maintaining our manufacturing autonomy for the final product. Our team is looking forward to the continued clinical and platform expansions in 2024, and anticipate multiple milestone achievements in the next 12 months for investors."

“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”


Warren Buffett

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCBP News